NasdaqCM - Delayed Quote USD

NeuroMetrix, Inc. (NURO)

4.4400 +0.0300 (+0.68%)
At close: April 26 at 4:00 PM EDT
4.6400 +0.20 (+4.50%)
After hours: April 26 at 7:32 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
5,901.4250
5,901.4250
8,256.0730
8,253.4930
7,377.9750
Cost of Revenue
1,954.0120
1,954.0120
2,505.8330
2,331.8330
2,128.4170
Gross Profit
3,947.4130
3,947.4130
5,750.2400
5,921.6600
5,249.5580
Operating Expense
11,098.9340
11,098.9340
10,492.0060
8,206.2670
7,344.4620
Operating Income
-7,151.5210
-7,151.5210
-4,741.7660
-2,284.6070
-2,094.9040
Net Non Operating Interest Income Expense
257.1050
257.1050
325.1570
3.1500
--
Other Income Expense
364.9290
364.9290
--
3.1500
2.7090
Pretax Income
-6,529.4870
-6,529.4870
-4,416.6090
-2,281.4570
-2,092.1950
Net Income Common Stockholders
-6,529.4870
-6,529.4870
-4,416.6090
-2,281.4570
-2,092.1950
Diluted NI Available to Com Stockholders
-6,529.4870
-6,529.4870
-4,416.6090
-2,281.4570
-2,092.1950
Basic EPS
-5.60
-6.27
-4.97
-3.60
-5.52
Diluted EPS
-5.60
-6.27
-4.97
-3.60
-5.52
Basic Average Shares
991.7650
1,041.9910
889.5400
638.8800
376.8120
Diluted Average Shares
991.7650
1,041.9910
889.5400
638.8800
376.8120
Total Operating Income as Reported
-7,151.5210
-7,151.5210
-4,741.7660
-2,284.6070
-2,094.9040
Total Expenses
13,052.9460
13,052.9460
12,997.8390
10,538.1000
9,472.8790
Net Income from Continuing & Discontinued Operation
-6,529.4870
-6,529.4870
-4,416.6090
-2,281.4570
-2,092.1950
Normalized Income
-6,529.4870
-6,529.4870
-4,416.6090
-2,281.4570
-2,092.1950
Interest Income
257.1050
257.1050
325.1570
3.1500
--
Net Interest Income
257.1050
257.1050
325.1570
3.1500
--
EBIT
-7,151.5210
-7,151.5210
-4,741.7660
-2,284.6070
-2,094.9040
EBITDA
-7,095.8090
-7,095.8090
-4,692.3750
-2,208.2290
-2,004.9500
Reconciled Cost of Revenue
1,954.0120
1,954.0120
2,505.8330
2,331.8330
2,128.4170
Reconciled Depreciation
55.7120
55.7120
49.3910
76.3780
89.9540
Net Income from Continuing Operation Net Minority Interest
-6,529.4870
-6,529.4870
-4,416.6090
-2,281.4570
-2,092.1950
Normalized EBITDA
-7,095.8090
-7,095.8090
-4,692.3750
-2,208.2290
-2,004.9500
12/31/2020 - 7/22/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RPID Rapid Micro Biosystems, Inc.
0.9456
-0.46%
 
NAOV NanoVibronix, Inc.
0.7584
-1.25%
 
MYO Myomo, Inc.
3.4300
+0.29%
 
BJDX Bluejay Diagnostics, Inc.
0.6419
+16.50%
 
BBLG Bone Biologics Corporation
1.5300
-1.29%
 
OPGN OpGen, Inc.
0.5149
-3.21%
 
MOTS Motus GI Holdings, Inc.
0.0810
+1.25%
 
AHCO AdaptHealth Corp.
9.96
+3.97%
 
IINN Inspira Technologies Oxy B.H.N. Ltd.
1.8900
-0.53%
 
MGRM Monogram Orthopaedics, Inc.
2.4329
+3.09%